Sign in
4

Changes in Ownership

Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-13-053451

Chief Commercial Officer sold 13,860 shares at an average $3.76 ($52,058)

From the SEC's structured data for this filing

Trades in this filing

TEW WILLIAM P PHD · Chief Commercial Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2013-11-18 Sale : show line 1 in the form −5,000 $3.77 $18,851 42,125 D
2013-11-18 Sale : show line 2 in the form −5,000 $3.76 $18,808 37,125 D
2013-11-20 Sale : show line 3 in the form −3,860 $3.73 $14,400 33,265 D
Open-market sales · 13,860 sh · avg $3.76 · $52,058
Loading xslF345X03/doc4.xml…